Login / Signup

Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.

Qi-Dong XiaYang XunJun-Lin LuYu-Chao LuYuan-Yuan YangPeng ZhouJia HuCong LiShao-Gang Wang
Published in: Cell proliferation (2020)
The network pharmacological strategy integrates molecular docking to unravel the molecular mechanism of LQC. Akt1 is a promising drug target to reduce tissue damage and help eliminate virus infection.
Keyphrases
  • molecular docking
  • signaling pathway
  • molecular dynamics simulations
  • cell proliferation
  • coronavirus disease
  • sars cov
  • oxidative stress
  • emergency department
  • human health
  • network analysis
  • drug induced